Equity Analysis /
United States of America

US : Ocular Therapeutix, Inc. - OCUL | Management Updates Interim Top Line Data for OTX-TIC Ahead of Glaucoma 360

    CGS-CIMB
    20 January 2021
    Published byCGS-CIMB

    On Wednesday, before market open, Ocular Therapeutix announced data on OTX-TIC (see slides here), a travoprost intracameral implant for the treatment of patients with primary open angle glaucoma or ocular hypertension, which will be presented at the virtual Glaucoma 360 New Horizons Forum on Januar